• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

News

Article

August 8, 2023

Burden of Aging-Related Comorbidities Higher in Women, Those with HIV

Author(s):

Luke Halpern, Assistant Editor

The burden of aging-related comorbidities was higher across every age category in women compared to men, and increased with age.

The overall burden of non-AIDS aging-related comorbidities (NACM) is higher in women versus men, particularly among persons with HIV (PWH), according to the results of a study published in the Journal of the American Medical Association.

Image credit: fizkes - stock.adobe.com

Image credit: fizkes - stock.adobe.com

Although antiretroviral therapy (ART) has dramatically improved the lifespan of PWH, a gap in comorbidity-free survival exists; between 2014 and 2016, PWH lived 16.3 fewer healthy years than peers without HIV. A factor contributing to this is NACM, which affects PWH earlier and has higher comorbidity rates compared to the general population.

Previous observations indicated that women with HIV had a significantly higher prevalence and incidence burden of aging-related comorbidities than women without HIV. The study researchers sought to assess the association between HIV and comorbidity burden by sex.

The cross-sectional analysis included data from US multisite observational cohort studies of women and men with HIV and socio-demographically comparable HIV-seronegative individuals. Participants in the study were followed from 2008 until the last observation point in 2019.

The main outcome of the study was comorbidity burden, which is the number of total comorbidities out of 10 assessed, per participant. Secondary outcomes included individual comorbidity prevalence, and linear regression examined the association of HIV status, sex, and age with comorbidity burden.

A total of 5929 participants were included in the study, which was comprised of 3238 women (55%) (2316 PWH, 922 HIV-seronegative) and 2691 men (45%) (1452 PWH, 1239 HIV-seronegative). Results of the trial showed a trend of increasing age category being associated with progressively higher mean (SD) NACM burden. For those under 40 years of age, the burden was 1.49 (1.32); ages 40 to 49 years, 2.58 (1.72); ages 50 to 59 years, 3.63 (1.80); ages 60 to 69 years, 4.21 (1.81); and ages 70 years or older, 4.41 (1.73).

Notably, PWH had a higher mean (SD) NACM burden overall compared to persons without HIV (3.47 [1.99] versus 3.03 [1.86]), in addition to across every age category. Furthermore, women had a higher mean (SD) NACM burden than men (3.36 [2.08] versus 3.24 [1.79]; P = .02). However, the differences were not statistically significant among PWH (3.51 [2.06] versus 3.40 [1.88]; P = .07) or persons without HIV (2.99 [2.09] versus 3.06 [1.66]; P = .37).

The estimated mean difference in NACM burden was significantly greater for women versus men in every age group among PWH, though the burden differed for women versus men across age categories among persons without HIV. Adjusting for covariates led to slightly weaker findings but still significantly associated NACM burden with sex.

Among PWH specifically, the estimated mean difference in NACM burden was much higher for women compared to men in every age strata, but this interaction was not significant. Univariable and multivariable results showed that individuals aged 70 years or older versus younger than 40 years of age had an estimated mean (SE) 2.95 (0.18) more comorbidities. Additionally, women with HIV had a 0.31 (0.09) higher comorbidity count versus men with HIV.

The study authors found that the most prevalent NACM were hypertension, psychiatric illness, dyslipidemia, liver disease, and bone disease, and that the distribution of prevalent NACM differed by sex.

Tools that exist to assess comorbidity risk in the general population focus on individual conditions, such as cardiovascular disease and fractures, and underestimate risk in PWH, the researchers wrote. Innovative, holistic approaches to promote healthy aging in HIV that prioritizes screening and prevention of multimorbidity should be supported, especially in consideration of the sociobiologic influences of sex and gender.

“Our findings underscore the need to accurately identify PWH at risk of multimorbidity to offer timely and tailored risk-modification interventions, with consideration given to sex and gender, so that outcomes can be optimized in this population,” the study investigators concluded.

Reference

Collins LF, Palella FJ, Mehta CC, et al. Aging-related comorbidity burden among women and men with or at-risk for HIV in the US, 2008-2019. JAMA Netw Open. 2023;6(8):e2327584. doi:10.1001/jamanetworkopen.2023.27584

Related Videos
Image credit: Dr_Microbe | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Related Content
Advertisement
Illustration of myocardial infarction
May 30th 2025

NLA 2025: Inclisiran With Standard Care Provides Rapid, Sustained Lowering of LDL-C in Patients With Recent Acute Coronary Syndrome

Luke Halpern, Assistant Editor
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
Woman can't eat bread and grain products because of gluten intolerance. A young celiac woman suffers from abdominal pain after eating fresh bread - Image credit: weyo | stock.adobe.com
May 30th 2025

FDA Grants Fast Track Designation to Drug Candidate for Celiac Disease

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
TKIs binding to target proteins | Image Credit: © Justlight - stock.adobe.com
May 30th 2025

Patient Reported Outcomes Show Improved Symptoms With Zongertinib for HER2-Mutated Non-Small Cell Lung Cancer

Alexandra Gerlach, Associate Editor
NLA 2025: The Complementary Roles of ANGPTL3 and ANGPTL4 in Lipid Regulation and Therapy
May 30th 2025

NLA 2025: The Complementary Roles of ANGPTL3 and ANGPTL4 in Lipid Regulation and Therapy

Sander Kersten, PhD Alana Hippensteele, Lead Editor
Related Content
Advertisement
Illustration of myocardial infarction
May 30th 2025

NLA 2025: Inclisiran With Standard Care Provides Rapid, Sustained Lowering of LDL-C in Patients With Recent Acute Coronary Syndrome

Luke Halpern, Assistant Editor
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
Woman can't eat bread and grain products because of gluten intolerance. A young celiac woman suffers from abdominal pain after eating fresh bread - Image credit: weyo | stock.adobe.com
May 30th 2025

FDA Grants Fast Track Designation to Drug Candidate for Celiac Disease

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
TKIs binding to target proteins | Image Credit: © Justlight - stock.adobe.com
May 30th 2025

Patient Reported Outcomes Show Improved Symptoms With Zongertinib for HER2-Mutated Non-Small Cell Lung Cancer

Alexandra Gerlach, Associate Editor
NLA 2025: The Complementary Roles of ANGPTL3 and ANGPTL4 in Lipid Regulation and Therapy
May 30th 2025

NLA 2025: The Complementary Roles of ANGPTL3 and ANGPTL4 in Lipid Regulation and Therapy

Sander Kersten, PhD Alana Hippensteele, Lead Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.